Antibiotic resistance leads to ‘nightmare’ bacteria. PPIs aren’t responsible for cognitive decline. Levothyroxine comes with risks for older patients. And Medicare formulary changes could be on the way.

Could gut bacteria trigger lupus? A simple ratio could uncover the cause of orthostatic hypotension. Does certolizumab have an unfair infection reputation? And how acid suppressors in infancy fuel allergies later on.

Does more marijuana mean fewer opioids? Acutely ill patients may not get enough VTE prophylaxis. Psoriatic arthritis patients aren’t sticking with biologics. And how many patients may be hiding from medical care?

Could European data privacy rules cost you big? Synthetic opioids drive increases in overdose deaths. Robocalls increase diabetic retinopathy screenings in low-income patients. And a new ranking points physicians toward South Dakota.

Why low-calorie sucralose may fuel weight gain. Diabetes racks up a hefty health bill. Is it time to rethink rifampin dosing for TB? And sessile serrated polyps may be detectable noninvasively.

Can androgen therapy improve male frailty? Empagliflozin could cut liver fat in diabetes. MicroRNAs might flag liver damage in HIV infection. And how triglycerides in cardiac muscle endanger women with HIV.

Why most heart failure may be preventable. Statins miss the mark in familial high cholesterol. Why mumps outbreaks are on the rise. And how using epileptic drugs in pregnancy affects school test scores.

Is kratom the answer to the opioid crisis? A simple screen may predict dementia in Parkinson’s disease. Should you fear steroids for inflammatory bowel disease? And specialists have adverse reactions to drug price proposals.

Treating H. pylori cut new gastric cancers by half. Some diabetes drugs up the risk of inflammatory bowel disease. Why older IBD patients don’t get optimal treatment. And the Supreme Court considers California’s abortion speech law.